Val Arkoosh, Pennsylvania's human services secretary, told a state House hearing in March
For most people taking GLP-1-based therapies including retatrutide gastrointestinal symptoms tend to be most pronounced during the early weeks of treatment and during periods of dose escalation
As it stands, you could argue taking a semaglutide would violate the spirit of the sport
Morgan describes GLP-1s as both a paradigm shift in the way obesity is treated and a life-and-death class of drugs, and estimates that as many as 30 million Americans could be using GLP-1s by 2030
While B12 is often marketed as an energy booster, there is no scientific evidence that excess B12 improves metabolism or energy levels in people who already have adequate levels
The plausible interaction concern is copper balance rather than a drug-drug effect: conditions affecting copper handling, such as Wilson's disease, are the relevant contraindication to raise with a clinician